VCM
USNA icon

Virtue Capital Management’s Usana Health Sciences USNA Stock Holding History

Virtue Capital Management’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-400
Closed -$38K – 450
2018
Q1 		$38K Buy
+400
New +$31K 0.02% 269

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Virtue Capital Management's USNA Position: Q2 2018 in Review

Virtue Capital Management sold out of Usana Health Sciences (USNA) in Q2 2018, closing a stake of 400 shares — an estimated $38K sold.

Virtue Capital Management first reported a position in USNA in Q1 2018 and held it in 1 quarter. The position peaked at $38K in Q1 2018. 189 funds tracked by Wall St. Rank hold USNA as of Q2 2018.

  • Virtue Capital Management reported no remaining Usana Health Sciences position as of Q2 2018 after selling out during the quarter.
  • Virtue Capital Management sold 400 Usana Health Sciences shares in Q2 2018, an estimated $38K.
  • Virtue Capital Management first reported a position in Usana Health Sciences in Q1 2018 and held it in 1 quarter.
  • Virtue Capital Management's Usana Health Sciences position peaked at $38K in Q1 2018.
  • 189 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2018.

Based on Virtue Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.